Cholestatic Liver Disease
11 clinical trials · Condition
◉ Watch Cholestatic Liver Disease
| Record | Firm | Date |
|---|---|---|
| Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease (NCT05045482) | Zydus Therapeutics Inc. | 2021-10-21 |
| A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS). (NCT04729751) | Mirum Pharmaceuticals, Inc. | 2021-09-09 |
| Probiotics in Pediatric Chronic Cholestasis (NCT04787419) | Indonesia University | 2020-09-01 |
| MRX-800: A Long-Term Safety Study of Maralixibat in the Treatment of Cholestatic Liver Disease in Subjects Who Previously Participated in a Maralixibat Study (NCT04168385) | Mirum Pharmaceuticals, Inc. | 2020-01-16 |
| Efficacy and Safety Study of TUDCA Compare UDCA to Treatment Chronic Cholestatic Liver Disease-PBC (NCT01829698) | Beijing Trendful Kangjian Medical Information Consulting Limited Company | 2009-08-01 |
Track Cholestatic Liver Disease automatically
Every clearance here is in the API, with alerts when new ones post.